6 natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of cd56bright nkg2a+++ cells, and yet display increased degranulation and higher perforin content

7 recurrent and prolonged infections in a child with a homozygous ifih1 nonsense mutation

8 novel combined immune deficiency and radiation sensitivity blended phenotype in an adult with biallelic variations in zap70 and rnf168

9 early diagnosis and treatment of invasive aspergillosis as a main determinant of outcome – review of literature according to the presented case report

10 severe anemia due to parvovirus b19 in a silver haired boy

11 bi-allelic mutations in stxbp2 reveal a complementary role for stxbp1 in cytotoxic lymphocyte killing

12 immunodeficiency in digeorge syndrome and options for treating cases with complete athymia.

13 corrigendum: natural killer cells from patients with recombinase-activating gene and non-homologous end joining gene defects comprise a higher frequency of cd56bright nkg2a+++ cells, and yet display increased degranulation and higher perforin content

14 Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.

15 Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results.

16 Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

17 Tualang honey ameliorates viral load, CD4 counts and improves quality of life in asymptomatic human immunodeficiency virus infected patients

18 Reconnaissance of the candidate genes involved in the pathogenesis of human immunodeficiency virus and targeted by antiretroviral therapy.

19 A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.

20 The Contribution of Kaposi's Sarcoma-Associated Herpesvirus to Mortality in Hospitalized Human Immunodeficiency Virus-Infected Patients Being Investigated for Tuberculosis in South Africa

21 Associação de carcinoma broncogênico com síndrome de Pancoast e síndrome da imunodeficiência adquirida Association of bronchogenic carcinoma with Pancoast's syndrome and acquired immunodeficiency syndrome

22 Safe Water and Hygiene Integration with Human Immunodeficiency Virus and Antenatal Services: Leveraging Opportunities for Public Health Interventions and Improved Service Uptake.

23 Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.

24 Alchemy: A web 2.0 real-time quality assurance platform for human immunodeficiency Virus, hepatitis C Virus, and BK Virus quantitation assays

25 Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype.

26 Assessing the Functional Relevance of Variants in the () in a Cohort of Patients With Primary Immunodeficiency.

27 The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data

28 [Recurrent infections of the upper aerodigestive tract in patients with primary immunodeficiency].

29 Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial.

30 Expansion of Viral Load Testing and the Potential Impact on Human Immunodeficiency Virus Drug Resistance.

31 Disclosure of human immunodeficiency virus status to children in South Africa: A comprehensive analysis.

32 Diagnostic Interpretation of Genetic Studies in Patients with Primary Immunodeficiency Diseases: A Working Group Report of the Primary Immunodeficiency Diseases Committee of the American Academy of Allergy, Asthma, and Immunology.

33 Low Exposure Busulfan Conditioning to Achieve Sufficient Multilineage Chimerism in Patients with Severe Combined Immunodeficiency.

34 Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.

35 Disseminated Autochthonous Dermal Leishmaniasis Caused by (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

36 The relationship between alcohol use and anxiety and retrospective attendance of primary care visits among women with human immunodeficiency virus

37 Distúrbios de leitura e escrita em portadora do vírus da imunodeficiência humana: estudo de caso Reading and writing disorders in a patient with the human immunodeficiency virus: a case study

38 Spatiotemporal distribution of acquired immunodeficiency syndrome incidence in Brazil between 2012 and 2016.

39 Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation.

40 Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.

41 Experiences of women enrolled in a prevention of mother to child transmission of human immunodeficiency virus infection programme in Zimbabwe.

42 Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon

43 Human immunodeficiency virus type-1 Tat protein induces secretory leukocyte protease inhibitor expression in African green monkey but not human cells.

44 Disseminated Masquerading as Pulmonary Tuberculosis in a Patient With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome.

45 Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?

46 Male involvement in prevention of mother to child transmission of human immunodeficiency virus and associated factors in Enebsiesarmider District, north West Ethiopia, 2018: a cross-sectional study.

47 Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review

48 Altered Intestinal Permeability and Fungal Translocation in Ugandan Children With Human Immunodeficiency Virus

49 Subclinical Vascular Disease in Children With Human Immunodeficiency Virus in Uganda Is Associated With Intestinal Barrier Dysfunction

50 Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study

51 Exercise and Vitamin E Intake Are Independently Associated with Metabolic Abnormalities in Human Immunodeficiency Virus—Positive Subjects: A Cross-Sectional Study

52 Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance

53 Effects of Immunonutrition in Advanced Human Immunodeficiency Virus Disease: A Randomized Placebo-controlled Clinical Trial (Promaltia Study)

54 Recurrence and Occurrence of Kaposi’s Sarcoma in Patients Living With Human Immunodeficiency Virus (HIV) and on Antiretroviral Therapy, Despite Suppressed HIV Viremia

55 Effect of Dietary Intake and Protease Inhibitors on Serum Vitamin B12 Levels in a Cohort of Human Immunodeficiency Virus—Positive Patients

56 Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study

57 Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group

58 Intestinal mucosal inflammation associated with human immunodeficiency virus infection

59 The impact of active herpes simplex virus infection on human immunodeficiency virus load

60 Human Immunodeficiency Virus Infection in Patients with Solid-Organ Transplants: Report of Five Cases and Review

61 Impact of Timing of Antiretroviral Treatment and Birth Weight on Mother-to-Child Human Immunodeficiency Virus Transmission: Findings From an 18-Month Prospective Cohort of a Nationally Representative Sample of Mother–Infant Pairs During the Transition From Option A to Option B+ in Zimbabwe

62 Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence

63 Spectrum of Disease in Persons With Human Immunodeficiency Virus Infection in the United States

64 Zinc Status in Human Immunodeficiency Virus Type 1 Infection and Illicit Drug Use

65 Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

66 Deaths Attributable to Cancer in the US Human Immunodeficiency Virus Population During 2001–2015

67 Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

68 Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children

69 Diverse and High Prevalence of Human Papillomavirus Associated with a Significant High Rate of Cervical Dysplasia in Human Immunodeficiency Virus–Infected Women in Johannesburg, South Africa

70 Performance of Premarket Rapid Hepatitis C Virus Antibody Assays in 4 National Human Immunodeficiency Virus Behavioral Surveillance System Sites

71 Clinical Efficacy of High-Dose Acyclovir in Patients with Human Immunodeficiency Virus Infection: A Meta-Analysis of Randomized Individual Patient Data

72 Respiratory syncytial virus infection in human immunodeficiency virus-infected children

73 Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

74 Human Herpesvirus 8-Associated Hemophagocytic Lymphohistiocytosis in Human Immunodeficiency Virus-Infected Patients

75 Mortality, Human Immunodeficiency Virus (HIV) Transmission, and Growth in Children Exposed to HIV in Rural Zimbabwe

76 Enteric Infections and Diarrhea in Human Immunodeficiency Virus–Infected Persons: Prospective Community-Based Cohort Study

77 Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome

78 Efficacy of Risk-Reduction Counseling to Prevent Human Immunodeficiency Virus and Sexually Transmitted Diseases: A Randomized Controlled Trial

79 Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries

80 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and re-vaccination

81 Virucidal effect of stimulated eosinophils on human immunodeficiency virus type 1

82 Interactions of the Human Immunodeficiency Virus and Tuberculosis and the Implications for BCG Vaccination

83 Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

84 In vitro antiviral activities of sulfated polysaccharides from a marine microalga (Cochlodinium polykrikoides) against human immunodeficiency virus and other enveloped viruses

85 Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

86 Spectrum of disease in persons with human immunodeficiency virus infection in the United States

87 Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire

88 Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire

89 Human immunodeficiency virus (HIV)-related chronic relapsing inflammatory demyelinating polyneuropathy with multifocal unusual onion bulbs in sural nerve biopsy

90 Dietary Habits and Their Association with Metabolic Abnormalities in Human Immunodeficiency Virus—Related Lipodystrophy

91 Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men

92 Herpes Simplex Virus Infection as a Risk Factor for Human Immunodeficiency Virus Infection in Heterosexuals

93 Zidovudine therapy protects against Salmonella bacteremia recurrence in human immunodeficiency virus-infected patients

94 Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

95 Bacterial Enteric Infections in Persons Infected with Human Immunodeficiency Virus

96 Intestinal mucosal inflammation associated with human immunodeficiency virus infection

97 [Using text mining to identify gap in acquired immunodeficiency syndrome related information dissemination between the official channel delivery and the needs of adolescents]

98 Understanding the Relationship Between Nursing Home Experience With Human Immunodeficiency Virus and Patient Outcomes.

99 slovene national registry of patients with primary immunodeficiency

100 predictors of human immunodeficiency virus and tuberculosis co-infection

101 alopecia areata and vitiligo as primary presentations in a young male with human immunodeficiency virus

Keyword Connections

Journals

Research Groups

Bibliographies